Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Patients will be randomized prospectively to one of two groups. One group will receive 5
mg/kg of 1% lidocaine, and the other will receive .9 normal saline, instilled into their VAC
sponge ½ hour prior to VAC dressing change. All patients will complete a pain assessment tool
prior to receiving the instilled lidocaine/placebo, immediately after the procedure and 1
hour after the procedure. Pain scores will then be compared between the lidocaine and placebo
groups.
Risks: Lidocaine toxicity is a potential risk, but 5 mg/kg of 1 % Lidocaine is below toxicity
thresholds in an adult.